Match Document Document Title
9040036 Compositions for probiotic recolonisation therapy  
The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in...
9034312 Extracellular matrix compositions for the treatment of cancer  
The present invention is directed to methods of inhibiting cancer cell growth or proliferation by contacting the cancer cell with an extracellular matrix (ECM) composition. Also provided are...
9028841 Synergistic bacterial compositions and methods of production and use thereof  
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
9029139 Omentum as a source of stromal/stem cells and medical treatment using stromal/stem cells  
Methods for generating and using omentum cells, and particularly stromal cells and/or omentum stem cells, in medical treatments such as tissue repair and regeneration to facilitate healing from...
9023338 Cancer stem cell antigen vaccines and methods  
Method of stimulating an immune response (e.g., to treat cancer) include administering to a patient a composition including dendritic cells that present cancer stem cell antigens. Compositions...
9017657 Islet cell cluster produced from human umbilical cord mesenchymal stem cells  
The invention relates to a cell culture method, particularly to a co-culture method for human mesenchymal stem cells and target animal cells, in order to solve the problem that animal cells are...
9017658 Cardiac tissue repair by mitotically inactivated pluripotent and/or embryonic stem cells  
The present invention is directed to the use of mitotically and/or lethally inactivated stem cells for the repair of damaged organs and/or tissues. Stem cells are mitotically and/or lethally...
9011840 Activated mesenchymal stem cells for wound healing and impaired tissue regeneration  
Inflammatory cytokines e.g. IFN-γ, serve as initiating stimuli for mesenchymal stem cell (MSC) immunosuppresive activity in vivo. Other inflammatory cytokines, such as TNF alpha, the molecule...
9011837 Tissue-engineered endothelial and epithelial implants repair multilaminate tubular airway structure  
Endothelial implants restore vascular homeostasis after injury without reconstituting vascular architecture. Endothelial cells line the vascular epithelium and underlying vasa vasorum precluding...
9011834 Compositions and methods  
Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders...
9011836 Methods of treating pigs with Bacillus strains  
Disclosed are methods of administering at least two Bacillus strains to a pig, such as female breeding stock, nursery pigs, or other pigs. The Bacillus strains inhibit Clostridium in litters borne...
9005885 Bioartificial lung  
Presented is an airway organ bioreactor apparatus, and methods of use thereof, as well as bioartificial airway organs produced using the methods, and methods of treating subjects using the...
9006411 Neuron-specific retrograde transport vector  
The present invention provides a lentiviral vector system having a higher titer, while sustaining an excellent retrograde transport ability, particularly, in the brain. The present invention also...
9005969 Generation of novel bone forming cells (monoosteophils) from LL-37 treated monocytes  
In one embodiment, a monocyte derived bone-forming cell population is provided. In one embodiment, the cell population comprises an isolated monocyte cell population treated with an effective dose...
8999317 Methods and compositions related to the structure and function of APOBEC3G  
Disclosed are methods and compositions related to the structure and function of APOBEC3G.
8992906 Compositions and methods for engraftment and increasing survival of adult muscle stem cells  
Embodiments herein relate to compositions and methods for engraftment of and increasing survival of muscle cells in a subject in need thereof. In certain embodiments, compositions including...
8993318 Pathogen restriction factors  
The use of interferon induced transmembrane protein 1, 2, or 3 (IFITM1, 2, or 3) as a viral restriction factor, and methods of using the same to produce virus, transgenic animals expressing...
8986671 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof  
The present invention provides muscle-derived progenitor cells that show long-term survival following transplantation into body tissues and which can augment soft tissue following introduction...
8986987 Herpesvirus of turkeys vectored vaccine against avian influenza in poultry  
The present application applies to the field of veterinary vaccines, in particular of vaccines for poultry against avian influenza. The vaccine is based on a recombinant viral vector expressing...
8986706 Newcastle disease virus vectored herpesvirus vaccines  
The present invention encompasses recombinant Newcastle Disease Virus-Herpesvirus vaccines or compositions. The invention encompasses recombinant NDV vectors encoding and expressing herpesvirus...
8986675 Compositions and methods for prevention and treatment of obesity and obesity related metabolic syndrome  
The present invention relates to the prevention and treatment of obesity and obesity related metabolic syndrome, particularly to the prevention and treatment of obesity by changing intestinal...
8986708 Combinations of gene deletions for live attenuated Shigella vaccine strains  
Shigella vaccine strains whose primary attenuating feature is deletion of the virG(icsA) gene and additional two or more deletions in setAB(shET1), senA(shET2), senB(shET2-2), stxAB, and msbB2...
8986679 Somatic stem cells  
A method of treating a cellular proliferative disorder in a subject by obtaining from a subject a bodily fluid sample containing a plurality of cells, incubating the sample with EDTA or heparin in...
8980289 Intestine immunomodulator  
The purpose of the present invention is to provide a better intestine immunomodulator. The intestine immunomodulator of the present invention comprises bacterial cells or a bacterial component of...
8980295 Multifunctional in situ polymerized network via thiol-ene and thiol-maleimide chemistry  
Biomaterials that support cell attachment and growth are provided. In one aspect, biomaterials are provided comprising a first polymer matrix comprising reactive amino moieties and a second...
8980611 Compositions and methods for reducing the pathogen content of meat or meat products  
Compositions and methods useful for reducing or eliminating the presence of pathogens in meat or meat products are disclosed. Administration of one or more lactic acid producing microorganisms to...
8968719 Live, oral vaccine for protection against Shigella dysenteriae serotype 1  
The invention relates to Salmonella typhi Ty21a comprising core-linked Shigella dysenteriae serotype 1 O-specific polysaccharide (O-Ps) and DNA encoding O antigen biosynthesis, said DNA selected...
8968721 Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same  
The disclosure relates to a solid glass matrix of polysaccharides, monossaccharides or disaccharides in combination with polyols as delivery vehicles for preservation and post gastric...
8968718 Bioremediation method for accelerated biological decomposition of petroleum hydrocarbons in sea ice-covered polar regions, and bacteria and enzyme mixtures as agents for carrying out said method  
A bacterial mixture usable in an inoculum usable in a bioremediateion method for accelerated biological degradation of petroleum hydrocarbons in a sea ice-covered polar region includes a plurality...
8961995 Methods and compositions for alphavirus replicons  
The present invention provides alphavirus replicons and methods of their use in producing heterologous protein.
8962317 Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration  
The present application relates to stem cells isolated from various sources within the body of a patient or of a healthy donor and identified by the presence of the interleukin 12 (IL-12)...
8956626 Modified viral strains and method for improving the production of vaccine seeds of influenza virus  
Modified influenza A/PR/8/34 virus and reassortant influenza A/PR/8/34 virus including a modified PB1 gene and methods for improving the production of HA (hemagglutinin) and NA (neuraminidase)...
8956590 Compositions and methods for reducing the incidence of equine digestive disorders  
The present invention encompasses compositions and methods of reducing the incidence of equine digestive disorders. A combination of either composition A (ASSURE PLUS®) and composition B (ASSURE®)...
8951510 T-cell receptor and nucleic acid encoding the receptor  
A polypeptide comprising a polypeptide consisting of an amino acid sequence shown in SEQ ID NO: 5 of Sequence Listing or a polypeptide consisting of an amino acid sequence having deletion,...
8951538 Exopolysaccharide of Shigella sonnei bacteria, method for producing same, vaccine and phamaceutical composition containing same  
For the first time, an O-specific polysaccharide antigen that is a Shigella sonnei, phase I, exopolysaccharide has been produced and characterized, said exopolysaccharide being an authentic...
8951572 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts  
A method of treating a renal, hepatic or enzyme-deficiency disorder in a subject in need thereof is disclosed. The method is effected by transplanting into the subject tissue derived from a human...
8945532 Anti-aging formulations  
A dietary supplement based on fucoidan, blue-green algae, phycocyanin and phenylethylamine is fortified with one or more of curcumin, silymarin, resveratrol, astragalus root extract, astragoloside...
8945587 Synthetic lipid biology for combinatorial engineering of endotoxin  
The present disclosure generally relates to genetic engineering of bacteria. More particularly, the present disclosure relates to genetic engineering of Gram-negative bacteria expressing different...
8945539 Enzyme and prebiotic combinations for enhancing probiotic efficacy  
This disclosure relates to enhancing growth and/or activity of lactobacilli using a prebiotic formulation which includes iso-malto oligosaccharides and α-galactosidase; and to enhancing growth...
8932575 Compositions and methods for inducing migration by dendritic cells and an immune response  
Compositions and methods of activating dendritic cells with LMP1 and LMP1-activated dendritic cell based compositions and methods are effective for dendritic cell therapy and provide an adjuvant...
8932846 Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins  
Recombinant immunogenic compositions, and methods for the manufacture and use, are provided for the prevention and treatment of intracellular pathogen diseases in humans and animals. The...
8932578 Cell and enzyme compositions for modulating ale acids, cholesterol and triglycerides  
The invention relates to immobilized or encapsulated enzyme and/or cells to lower bile acids and cholesterol. The invention also relates to methods of quantitatively measuring bile acids. The...
8932604 Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens  
Recombinant multivalent non-pathogenic Marek's Disease virus constructs that encode and express both Infectious Laryngotracheitis Virus and Newcastle Disease virus protein antigens, and methods of...
8933048 Methods of treating cardiomyopathy  
A method of treating a cardiomyopathy in a subject includes administering to the subject a therapeutically effective amount of an agent that modulates contractile function in myocardial tissue of...
8927275 Differentiation of human embryonic and induced pluripotent stem cells  
The invention relates to culture systems, methods, and conditions that allow pluripotent undifferentiated hESCs or iPSCs to progressively and uniformly differentiate into cells of the chondrogenic...
8926946 Peptides for transport of therapeutics and their carriers in mouse models and humans  
A system for targeted delivery of agents (e.g., molecular probes, diagnostic agents, therapeutic agents, imaging agents, research or analytical compounds, enzymes, peptides, proteins, lipids,...
8921101 Attenuated poliovirus  
A novel and stable attenuated poliovirus, which replicates in neuroblastoma cells, is produced by engineering an indigenous replication element (cre), into the 5′ non-translated genomic region and...
8921060 Health-beneficial preparation and production method  
The invention relates to the area of health-beneficial preparations and production methods thereof, in particular to the use of thermally pre-treated Lactobacillus preparations having specific...
8916371 Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof  
The present invention provides compositions or vaccines that contain a recombinant EHV-1 that elicit an immune response in animals against equine herpesvirus, including compositions comprising...
8916144 Proangiogenic compositions, method for preparing same, and uses thereof  
The invention relates to novel proangiogenic compositions, to the method for preparing same, and to the uses thereof, particularly for preventing or treating any disease causing ischemic-type...